ID   DYRK3_HUMAN             Reviewed;         588 AA.
AC   O43781; D3DT79; Q7Z752; Q9HBY6; Q9HBY7;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2007, sequence version 3.
DT   15-MAR-2017, entry version 163.
DE   RecName: Full=Dual specificity tyrosine-phosphorylation-regulated kinase 3;
DE            EC=2.7.12.1 {ECO:0000269|PubMed:9748265};
DE   AltName: Full=Regulatory erythroid kinase {ECO:0000303|PubMed:10779429};
DE            Short=REDK {ECO:0000303|PubMed:10779429};
GN   Name=DYRK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, AND
RP   AUTOPHOSPHORYLATION.
RC   TISSUE=Fetal brain;
RX   PubMed=9748265; DOI=10.1074/jbc.273.40.25893;
RA   Becker W., Weber Y., Wetzel K., Eirmbter K., Tejedor F.J.,
RA   Joost H.-G.;
RT   "Sequence characteristics, subcellular localization, and substrate
RT   specificity of DYRK-related kinases, a novel family of dual
RT   specificity protein kinases.";
RL   J. Biol. Chem. 273:25893-25902(1998).
RN   [2]
RP   SEQUENCE REVISION TO N-TERMINUS.
RA   Becker W.;
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9845759;
RA   Xia J., Yang X., Ruan Q., Pan Q., Liu C., Xie W., Deng H.;
RT   "Molecular cloning and characterization of novel protein kinase gene
RT   DYRK3.";
RL   Zhonghua Yi Xue Yi Chuan Xue Za Zhi 15:327-332(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RC   TISSUE=Skeletal muscle;
RX   PubMed=10779429;
RA   Lord K.A., Creasy C.L., King A.G., King C., Burns B.M., Lee J.C.,
RA   Dillon S.B.;
RT   "REDK, a novel human regulatory erythroid kinase.";
RL   Blood 95:2838-2846(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RA   Zhou Z.M.;
RT   "Cloning of the human testis-specific dual-specificity tyrosine-(Y)-
RT   phosphorylation regulated kinase 5 (DYRK5) gene.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Raya A., de la Luna S.;
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=20167603; DOI=10.1074/jbc.M110.102574;
RA   Guo X., Williams J.G., Schug T.T., Li X.;
RT   "DYRK1A and DYRK3 promote cell survival through phosphorylation and
RT   activation of SIRT1.";
RL   J. Biol. Chem. 285:13223-13232(2010).
RN   [11]
RP   SUBCELLULAR LOCATION, FUNCTION, AND MUTAGENESIS OF LYS-238.
RX   PubMed=23415227; DOI=10.1016/j.cell.2013.01.033;
RA   Wippich F., Bodenmiller B., Trajkovska M.G., Wanka S., Aebersold R.,
RA   Pelkmans L.;
RT   "Dual specificity kinase DYRK3 couples stress granule
RT   condensation/dissolution to mTORC1 signaling.";
RL   Cell 152:791-805(2013).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-239.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual-specificity kinase which possesses both
CC       serine/threonine and tyrosine kinase activities. Negative
CC       regulator of EPO-dependent erythropoiesis, may place an upper
CC       limit on red cell production during stress erythropoiesis.
CC       Inhibits cell death due to cytokine withdrawal in hematopoietic
CC       progenitor cells (PubMed:10779429). May act by regulating CREB/CRE
CC       signaling (By similarity). Stabilizes and prevents stress granule
CC       disassembly thereby regulating mTORC1 signaling during cellular
CC       stress. During stressful conditions, DYRK3 partitions to the
CC       stress granule from the cytosol, as well as mTORC1 components,
CC       which prevents mTORC1 signaling. When stress signals are gone, the
CC       kinase activity of DYRK3 is required for the dissolution of stress
CC       granule and mTORC1 relocation to the cytosol, and promotes the
CC       phosphorylation of the mTORC1 inhibitor, AKT1S1, allowing full
CC       reactivation of mTORC1 signaling (PubMed:23415227). Promotes cell
CC       survival upon genotoxic stress through phosphorylation of SIRT1.
CC       This in turn inhibits TP53 activity and apoptosis
CC       (PubMed:20167603). {ECO:0000250|UniProtKB:Q922Y0,
CC       ECO:0000269|PubMed:10779429, ECO:0000269|PubMed:20167603,
CC       ECO:0000269|PubMed:23415227}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:9748265}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Inhibited by harmine, leucettamine B and
CC       leucettine L41.
CC   -!- SUBUNIT: Interacts with SIRT1. {ECO:0000250|UniProtKB:Q922Y0}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10779429,
CC       ECO:0000269|PubMed:20167603}. Cytoplasmic granule
CC       {ECO:0000269|PubMed:20167603, ECO:0000269|PubMed:23415227}.
CC       Note=Shuttles between cytoplasm and stress granules. Localized
CC       predominantly on distinct speckles distributed throughout the
CC       cytoplasm of the cell (PubMed:20167603). At low concentration,
CC       showns a homogeneous distribution throughout the cytoplasm and
CC       does not condense in speckles. During oxidative and osmotic
CC       stress, localizes to stress granules (PubMed:20167603).
CC       {ECO:0000269|PubMed:20167603}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Long;
CC         IsoId=O43781-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=O43781-2; Sequence=VSP_026178, VSP_026179;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are highly expressed
CC       in testis and in hematopoietic tissue such as fetal liver, and
CC       bone marrow. Isoform 2 is the predominant form in testis. Isoform
CC       1 is the predominant form in fetal liver and bone marrow. Isoform
CC       1 and isoform 2 are present at low levels in heart, pancreas,
CC       lymph node, and thymus. {ECO:0000269|PubMed:10779429}.
CC   -!- INDUCTION: By EPO/erythropoietin. {ECO:0000269|PubMed:10779429}.
CC   -!- DOMAIN: The N-terminal domain is required for stress granule
CC       localization (PubMed:23415227).
CC   -!- PTM: Autophosphorylated on tyrosine residues (PubMed:9748265).
CC       {ECO:0000269|PubMed:9748265}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MNB/DYRK subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y12735; CAA73266.2; -; mRNA.
DR   EMBL; AF186773; AAG17028.1; -; mRNA.
DR   EMBL; AF186774; AAG17029.1; -; mRNA.
DR   EMBL; AF327561; AAK16443.1; -; mRNA.
DR   EMBL; AY590695; AAT06103.1; -; mRNA.
DR   EMBL; AL591846; CAI13539.1; -; Genomic_DNA.
DR   EMBL; AL591846; CAI13541.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93533.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93534.1; -; Genomic_DNA.
DR   EMBL; BC015501; AAH15501.1; -; mRNA.
DR   CCDS; CCDS30999.1; -. [O43781-1]
DR   CCDS; CCDS31000.1; -. [O43781-2]
DR   RefSeq; NP_001004023.1; NM_001004023.1. [O43781-2]
DR   RefSeq; NP_003573.2; NM_003582.2. [O43781-1]
DR   RefSeq; XP_005273372.1; XM_005273315.4. [O43781-2]
DR   UniGene; Hs.164267; -.
DR   ProteinModelPortal; O43781; -.
DR   SMR; O43781; -.
DR   BioGrid; 114022; 5.
DR   IntAct; O43781; 5.
DR   STRING; 9606.ENSP00000356076; -.
DR   BindingDB; O43781; -.
DR   ChEMBL; CHEMBL4575; -.
DR   GuidetoPHARMACOLOGY; 2012; -.
DR   iPTMnet; O43781; -.
DR   PhosphoSitePlus; O43781; -.
DR   BioMuta; DYRK3; -.
DR   MaxQB; O43781; -.
DR   PaxDb; O43781; -.
DR   PeptideAtlas; O43781; -.
DR   PRIDE; O43781; -.
DR   DNASU; 8444; -.
DR   Ensembl; ENST00000367106; ENSP00000356073; ENSG00000143479. [O43781-2]
DR   Ensembl; ENST00000367108; ENSP00000356075; ENSG00000143479. [O43781-2]
DR   Ensembl; ENST00000367109; ENSP00000356076; ENSG00000143479. [O43781-1]
DR   GeneID; 8444; -.
DR   KEGG; hsa:8444; -.
DR   UCSC; uc001hei.4; human. [O43781-1]
DR   CTD; 8444; -.
DR   DisGeNET; 8444; -.
DR   GeneCards; DYRK3; -.
DR   HGNC; HGNC:3094; DYRK3.
DR   HPA; HPA075041; -.
DR   MIM; 603497; gene.
DR   neXtProt; NX_O43781; -.
DR   OpenTargets; ENSG00000143479; -.
DR   PharmGKB; PA27551; -.
DR   eggNOG; KOG0667; Eukaryota.
DR   eggNOG; ENOG410XPET; LUCA.
DR   GeneTree; ENSGT00760000119032; -.
DR   HOGENOM; HOG000220863; -.
DR   HOVERGEN; HBG051426; -.
DR   InParanoid; O43781; -.
DR   KO; K18669; -.
DR   OMA; LKQYKHH; -.
DR   OrthoDB; EOG091G0Q46; -.
DR   PhylomeDB; O43781; -.
DR   TreeFam; TF314624; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   SignaLink; O43781; -.
DR   SIGNOR; O43781; -.
DR   ChiTaRS; DYRK3; human.
DR   GeneWiki; DYRK3; -.
DR   GenomeRNAi; 8444; -.
DR   PRO; PR:O43781; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143479; -.
DR   CleanEx; HS_DYRK3; -.
DR   ExpressionAtlas; O43781; baseline and differential.
DR   Genevisible; O43781; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IMP:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030218; P:erythrocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0080135; P:regulation of cellular response to stress; IMP:UniProtKB.
DR   GO; GO:1903432; P:regulation of TORC1 signaling; IMP:UniProtKB.
DR   GO; GO:0035617; P:stress granule disassembly; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    588       Dual specificity tyrosine-
FT                                phosphorylation-regulated kinase 3.
FT                                /FTId=PRO_0000085938.
FT   DOMAIN      209    522       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     215    223       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     288    291       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    335    335       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     238    238       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159,
FT                                ECO:0000269|PubMed:23415227}.
FT   MOD_RES     369    369       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q922Y0}.
FT   VAR_SEQ       1     20       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10779429,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_026178.
FT   VAR_SEQ      21     26       PPQQRR -> MKWKEK (in isoform 2).
FT                                {ECO:0000303|PubMed:10779429,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_026179.
FT   VARIANT     239    239       M -> L. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040464.
FT   MUTAGEN     238    238       K->M: Kinase dead; Induces formation of
FT                                stress granules-like in absence of
FT                                stress. {ECO:0000269|PubMed:23415227}.
FT   CONFLICT    313    313       R -> H (in Ref. 9; AAH15501).
FT                                {ECO:0000305}.
FT   CONFLICT    396    396       G -> R (in Ref. 1; CAA73266).
FT                                {ECO:0000305}.
SQ   SEQUENCE   588 AA;  65714 MW;  9950F51C39AFED82 CRC64;
     MGGTARGPGR KDAGPPGAGL PPQQRRLGDG VYDTFMMIDE TKCPPCSNVL CNPSEPPPPR
     RLNMTTEQFT GDHTQHFLDG GEMKVEQLFQ EFGNRKSNTI QSDGISDSEK CSPTVSQGKS
     SDCLNTVKSN SSSKAPKVVP LTPEQALKQY KHHLTAYEKL EIINYPEIYF VGPNAKKRHG
     VIGGPNNGGY DDADGAYIHV PRDHLAYRYE VLKIIGKGSF GQVARVYDHK LRQYVALKMV
     RNEKRFHRQA AEEIRILEHL KKQDKTGSMN VIHMLESFTF RNHVCMAFEL LSIDLYELIK
     KNKFQGFSVQ LVRKFAQSIL QSLDALHKNK IIHCDLKPEN ILLKHHGRSS TKVIDFGSSC
     FEYQKLYTYI QSRFYRAPEI ILGSRYSTPI DIWSFGCILA ELLTGQPLFP GEDEGDQLAC
     MMELLGMPPP KLLEQSKRAK YFINSKGIPR YCSVTTQADG RVVLVGGRSR RGKKRGPPGS
     KDWGTALKGC DDYLFIEFLK RCLHWDPSAR LTPAQALRHP WISKSVPRPL TTIDKVSGKR
     VVNPASAFQG LGSKLPPVVG IANKLKANLM SETNGSIPLC SVLPKLIS
//
